| Document |
Document Title |
|
WO/2022/158442A1 |
The present invention provides, as a radioactive halogen-labeled precursor compound that is highly stable and reactive, a compound represented by general formula (II) [in the formula, R1 and R2 each independently represent an alkyl group...
|
|
WO/2022/149462A1 |
A light-absorbing material according to one embodiment of the present disclosure includes a compound represented by formula (1) as a main component. In formula (1): R1 to R30 are independent of each other and include at least one element...
|
|
WO/2022/149461A1 |
The nonlinear light absorption material according to one mode of the present disclosure contains, as a main component, a compound represented by formula (1). In formula (1), R1 to R15 each independently include at least one atom selected...
|
|
WO/2022/138603A1 |
A sulfonate composition production method comprising: reacting a diester (hereinafter, the (A) component) of a prescribed unsaturated carboxylic acid with (C) a sulfonating agent in the presence of (B) at least one solvent selected from ...
|
|
WO/2022/133544A1 |
Cannabidiol (CBD) cannabinoids and CBD cannabinoid analogues with, inter alia, antimicrobial activity, synthetic methods for the preparation thereof and medical uses and formulations containing same.
|
|
WO/2022/138602A1 |
The present invention is a sulfonate composition comprising, in predetermined mass ratios, (A) a compound represented by formula (1), (B) an organic solvent, (C) an inorganic metallic compound, and (D) water. (1): ROOC-(CH2)p-CH(SO3M)-CH...
|
|
WO/2022/138659A1 |
Provided is a method for producing a fluorovinyl ether compound capable of suppressing the generation of by-products. The method for producing a fluorovinyl ether compound of the present invention is a method for producing a fluoroviny...
|
|
WO/2022/129651A1 |
The present invention provides tyrosinase-inhibiting molecules of general formula (I) and a dermopharmaceutical or cosmetic composition that includes at least one of said tyrosinase-inhibiting molecules.
|
|
WO/2022/123575A1 |
The present invention pertains to present invention relates to a device comprising conjugate/s, and uses thereof in depleting at least one amine, specifically ammonia from body fluids. The present disclosure further provides systems, app...
|
|
WO/2022/116596A1 |
The invention relates to a concrete micro-foaming agent. The concrete micro-foaming agent contains the following components in parts by weight: 100-150 parts of a sulfonating agent, 0-100 parts of an alkaline agent, 100-200 parts of a un...
|
|
WO/2022/113814A1 |
Provided are: a radiation-sensitive resin composition able to exhibit satisfactory levels of sensitivity, LWR performance and CDU performance; a method for forming a pattern; and an onium salt compound. This radiation-sensitive resin com...
|
|
WO/2022/114138A1 |
Provided is a novel method for producing a (1R,2R,3R,5R,6R)-2-amino-6-fluoro-3-[(4-fluorophenyl)methoxy
]bicycle[3.1.0]hexane-2,6-dicarboxylic acid. This production method is characterized by relying on the conversion from a compound rep...
|
|
WO/2022/099826A1 |
The present invention relates to a Gemini polyoxyethylene ether succinate surfactant for oil displacement and a preparation method therefor. The present invention is characterized in that the surfactant is a Gemini alkylphenol polyoxyeth...
|
|
WO/2022/099374A1 |
The present invention relates to a compound of formula (I): or a salt or solvate thereof, combinations comprising same, uses and methods thereof, and kits comprising same.
|
|
WO/2022/102190A1 |
Provided is a pattern formation method and a radiation-sensitive resin composition that can exhibit a sufficient level of sensitivity and CDU performance in a case in which next-generation technology is applied. A radiation-sensitive r...
|
|
WO/2022/100195A1 |
The present disclosure provides a method for preparing 2-fluoro-5-methoxybenzenesulfonyl chloride. 3-bromo-4-fluoroanisole is used as a raw material and reacts with a metal or metal reagent to obtain an aryl metal reagent, which then rea...
|
|
WO/2022/090448A1 |
The present invention relates to a novel acylating reagent, a method for its preparation, and a method of using it for acylating at the N-terminal of a peptide or a protein. The novel acylating reagent may be a compound which comprises 5...
|
|
WO/2022/093797A1 |
Electrolyte additives for energy storage devices comprising functional epoxides compounds are disclosed. Catalysts may be combined with the functional epoxides to create bi-component electrolyte additive systems, which can be utilized as...
|
|
WO/2022/079595A1 |
Embodiments of the present disclosure generally relate to processes for converting disulfides to conversion products and to processes for producing cysteic acid. In an embodiment, a process for converting cystine to a conversion product ...
|
|
WO/2022/036060A9 |
Crystalline forms of salts of Compound I are disclosed. Pharmaceutical compositions comprising the same, methods of treating cystic fibrosis using the same, and methods for making the same are also disclosed.
|
|
WO/2022/072693A1 |
A process for polymerizing at least one fluoromonomer in an aqueous medium containing initiator and hydrocarbon dispersing agent to form an aqueous dispersion of particles of fluoropolymer. The hydrocarbon dispersing agent comprises a co...
|
|
WO/2022/066678A1 |
The present invention provides, in part, TES-based lipid compounds of Formula (la), and sub-formulas thereof: or a pharmaceutically acceptable salt thereof. The compounds provided herein can be useful for delivery and expression of mRNA ...
|
|
WO/2022/056700A1 |
A photosensitive resin and a photoresist composition using same. The photosensitive resin comprises resin-type photosensitive anions and sulfonium salt cations, wherein in the structural formula of the resin-type photosensitive anion, R1...
|
|
WO/2022/055781A1 |
There is disclosed a process for recovering monoethanolamine from an aqueous mother liquor solution comprising the steps of: (a) adding excess ammonia or alkali hydroxide and a solvent to the aqueous solution comprised of monoethanolamin...
|
|
WO/2022/055780A1 |
There is disclosed a cyclic process for producing taurine from monoethanolamine comprising the steps of: (a) recovering monoethanolamine sulfate from an aqueous mother liquor solution; (b) reacting the monoethanolamine sulfate with sulfu...
|
|
WO/2022/052683A1 |
The present invention provides a method for preparing a water-soluble magnolol derivative and a honokiol derivative, methods for preparing intermediates of a water-soluble magnolol derivative and a honokiol derivative, and a related mono...
|
|
WO/2022/055782A1 |
There is disclosed a cyclic process for producing taurine from monoethanolamine comprising the steps of: (a) reacting monoethanolamine with ammonium sulfate in the recycling mother liquor to yield monoethanolamine sulfate; (b) reacting t...
|
|
WO/2022/042989A1 |
The invention relates to a secondary alkane sulfonate surfactant, wherein wherein greater than 50 wt.% of the secondary alkane sulfonate is C17 and/or C18 secondary alkane sulfonate; the invention also concerns a detergent composition co...
|
|
WO/2022/043138A1 |
The invention relates to a secondary alkane sulfonate surfactant, wherein at least 70 wt.% of the secondary alkane sulfonate is a secondary alkane sulfonate (SAS) surfactant having linear alkyl chains of from 15 to 18 carbon atoms; where...
|
|
WO/2022/046543A1 |
Alkane multi-sulfonic acids and salts thereof are provided. In embodiments, an alkane multi-sulfonic acid or salt thereof comprises an alkyl group and at least two sulfonic acid groups, the alkane multi-sulfonic acid having a total numbe...
|
|
WO/2022/046540A1 |
Haloalkane sulfonic acids and salts thereof are provided. In embodiments, a haloalkane sulfonic acid or salt thereof comprises an alkyl group, at least one sulfonic acid group, and one or more halogens selected from Cl, Br, I, and F, the...
|
|
WO/2022/040377A1 |
The present disclosure relates to methods of preparing compounds of Formula (VII) and salts thereof, and relates to compounds and combinations useful for the preparation. The present disclosure also relates to compounds being prepared by...
|
|
WO/2022/032868A1 |
Disclosed are a reaction system and method for preparing sodium N-methyltaurate. The reaction system comprises: an amination reaction kettle, an amination reaction product from which undergoes a reaction in a tubular reactor and then ent...
|
|
WO/2022/032869A1 |
Provided are a micro-interface strengthening system and method for preparing sodium N-methyl taurate, comprising an amination reaction kettle. A amination reaction product from the amination reaction kettle enters a first gas-liquid sepa...
|
|
WO/2022/033563A1 |
The present application relates to a JAK inhibitor compound and use thereof. Specifically, disclosed in the present application is a compound in a solid form as shown in formula (I), or an isotopically labeled compound thereof, or an opt...
|
|
WO/2022/031773A1 |
The present disclosure encompasses solid state forms of Fezolinetant, including salts and cocrystals of Fezolinetant, in embodiments crystalline polymorphs of Fezolinetant, processes for preparation thereof, and pharmaceutical compositio...
|
|
WO/2022/031909A1 |
A water dispersible sulfopolyester is provided wherein the sulfopolyester comprises: (a) residues of one or more dicarboxylic acids; (b) at least 4 mole percent and less than 8.5 mole percent of residues of at least one sulfomonomer; and...
|
|
WO/2022/031640A1 |
Active compounds of Formulas I – IX are provided herein that are useful as TREX1 inhibitors, which in turn is useful for stimulating the cGAS-STING pathway. As such, these compounds may be used in a method of treating disease or disord...
|
|
WO/2022/022367A1 |
Provided is a method for preparing a high-purity crystal. Specifically, the present invention relates to a method for preparing a Lenvatinib mesylate crystal C. The method comprises the following steps: 1) dissolving a Lenvatinib free ba...
|
|
WO/2022/020940A1 |
The present invention provides novel salts of remdesivir and crystalline forms thereof. Specific salts of remdesivir provided by the present invention include napsylate, tosylate, hydrochloride, phosphate, maleate, and oxalate. Also prov...
|
|
WO/2022/020963A1 |
A method for the synthesis of specialized pro-resolving mediators, structural isomers thereof and analogs thereof is disclosed herein. The method comprises reacting a compound of the formula (I): (I) wherein R1 is alkyl(C≤12), cycloalk...
|
|
WO/2022/022398A1 |
Provided are a salt and a crystal form of a pyrimidine compound, and preparation methods therefor. Specifically, provided are a salt and a crystal form of a compound I, covering a crystal form of the salt, and preparation methods therefor.
|
|
WO/2022/012483A1 |
The present invention relates to the field of agricultural acaricides, and in particular to a substituted phenyl sulfide compound and an application thereof. The substituted phenyl sulfide compound is as represented by general formula I....
|
|
WO/2022/015971A1 |
Process for upcycling a waste material to form alkylaromatic compounds is described herein. The process typically includes the steps of feeding a waste material containing hydrocarbon polymer(s) into a reactor containing a catalyst there...
|
|
WO/2022/010743A1 |
The present disclosure provides derivatives of amino acids that have branched alkyl structures and surface-active properties. The amino acid can be naturally-occurring or synthetic, or they may be obtained via a ring-opening reaction of ...
|
|
WO/2022/010744A1 |
The present disclosure provides derivatives of amino acids that have branched alkyl structures and surface-active properties. The amino acid can be naturally-occurring or synthetic, or they may be obtained via a ring-opening reaction of ...
|
|
WO/2022/002226A1 |
An alkylaniline polyether benzene sulfonate oil-displacement surfactant, which has a structure as represented by formula (I). A polyether chain in the structure of the alkylaniline polyether benzene sulfonate oil-displacement surfactant ...
|
|
WO/2021/261473A1 |
The present invention relates to a betaine monomer which includes a positively charged moiety and a negatively charged moiety that are equivalent to each other, wherein the positively charged moiety and the negatively charged moiety are ...
|
|
WO/2021/255552A1 |
Provided are amino acid based polymerizable compounds and their applications in ophthalmic devices. The amino acid based polymerizable compounds are of formula I: wherein R, R1, and R2 are as described herein.
|
|
WO/2021/251086A1 |
A first problem addressed by the present invention is to provide an active-ray-sensitive or radiation-sensitive resin composition with which a pattern having a favorable form can be obtained. Further, a second problem addressed by the pr...
|
